Literature DB >> 25896575

The Epidemiology of Amyotrophic Lateral Sclerosis in New Hampshire, USA, 2004-2007.

Tracie A Caller1, Angeline Andrews, Nicholas C Field, Patricia L Henegan, Elijah W Stommel.   

Abstract

BACKGROUND/AIMS: Trends in disease incidence and mortality can provide clues to disease etiology. Previously, we described a town in New Hampshire (N.H.), USA, with 25 times the expected incidence rate of amyotrophic lateral sclerosis (ALS). This study aimed to describe the incidence and mortality of ALS across the state to assess rates relative to other states and industrialized nations.
METHOD: A retrospective review of records from regional ALS centers, clinics and ALS organizations was conducted to obtain demographics and diagnostic details for patients diagnosed with ALS or primary lateral sclerosis in N.H. from January 2004 to December 2007. Data on mortality from review of death certificates were obtained for a similar time frame.
RESULTS: We identified 113 N.H. residents diagnosed with ALS in 2004-2007, yielding an age-standardized incidence rate ranging from 1.3 to 2.2 per 100,000 of the population per year. During the same period, the standardized mortality rate per 100,000 varied from 2.6 to 3.5. ALS was more common among men (ratio 1.6:1), who were more likely than women to have an earlier age at onset (59 ± 14.2 vs. 65 ± 11.8 years, p = 0.01).
CONCLUSION: While localized areas in N.H. with high ALS incidence rates have been reported previously, the overall incidence and mortality rates of ALS in N.H. are similar to those in other industrialized nations.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 25896575     DOI: 10.1159/000374117

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  6 in total

1.  Mechanisms of L-Serine Neuroprotection in vitro Include ER Proteostasis Regulation.

Authors:  R A Dunlop; J Powell; G J Guillemin; P A Cox
Journal:  Neurotox Res       Date:  2017-11-02       Impact factor: 3.911

2.  Prognostic Factors in Amyotrophic Lateral Sclerosis: A Population-Based Study.

Authors:  Mirian Conceicao Moura; Maria Rita Carvalho Garbi Novaes; Emanoel Junio Eduardo; Yuri S S P Zago; Ricardo Del Negro Barroso Freitas; Luiz Augusto Casulari
Journal:  PLoS One       Date:  2015-10-30       Impact factor: 3.240

3.  Risk factors in Swedish young men for amyotrophic lateral sclerosis in adulthood.

Authors:  Maria Åberg; Jenny Nyberg; Josefina Robertson; Georg Kuhn; Linus Schiöler; Hans Nissbrandt; Margda Waern; Kjell Torén
Journal:  J Neurol       Date:  2017-12-28       Impact factor: 4.849

4.  Assessing Cyanobacterial Harmful Algal Blooms as Risk Factors for Amyotrophic Lateral Sclerosis.

Authors:  Nathan Torbick; Beth Ziniti; Elijah Stommel; Ernst Linder; Angeline Andrew; Tracie Caller; Jim Haney; Walter Bradley; Patricia L Henegan; Xun Shi
Journal:  Neurotox Res       Date:  2017-10-03       Impact factor: 3.911

5.  Is Chronic Exposure to Raw Water a Possible Risk Factor for Amyotrophic Lateral Sclerosis? A Pilot Case-Control Study.

Authors:  Giuseppe Stipa; Antonio Ancidoni; Monica Mazzola; Emanuela Testai; Enzo Funari; Cristina Spera; Cinzia Fanelli; Alessia Mancini; Nicola Vanacore
Journal:  Brain Sci       Date:  2021-02-05

6.  Pesticide exposure assessed through agricultural crop proximity and risk of amyotrophic lateral sclerosis.

Authors:  Marco Vinceti; Tommaso Filippini; Federica Violi; Kenneth J Rothman; Sofia Costanzini; Carlotta Malagoli; Lauren A Wise; Anna Odone; Carlo Signorelli; Laura Iacuzio; Elisa Arcolin; Jessica Mandrioli; Nicola Fini; Francesco Patti; Salvatore Lo Fermo; Vladimiro Pietrini; Sergio Teggi; Grazia Ghermandi; Renato Scillieri; Caterina Ledda; Cristina Mauceri; Salvatore Sciacca; Maria Fiore; Margherita Ferrante
Journal:  Environ Health       Date:  2017-08-29       Impact factor: 5.984

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.